LncRNA Information | |||||
---|---|---|---|---|---|
ID | EL0461 | Name | ATXN7L3B | Aliases | lnc-SCA7 |
Species | Homo sapiens | Chromosome | 12 | Start site | 74537835 |
End site | 74545430 | Chain | plus | Exon NO. | 1 |
Assembly | GRCh38.p13 | Class | lncRNA | NCBI accession | N/A |
Ensembl | ENSG00000253719 | Sequence | N/A | Peptide-related | N/A |
CircRNA | yes | Exosomal | N/A | Structure | N/A |
Disease | |||||||||
---|---|---|---|---|---|---|---|---|---|
Disease | Drug/chemo/stress | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | ||
spinocerebellar ataxia type 7 | N/A | N/A | N/A | N/A | STAGA is required for the transcription initiation of miR-124, which in turn mediates the post-transcriptional cross-talk between lnc-SCA7, a conserved long noncoding RNA,and ATXN7 mRNA. In SCA7, mutations in ATXN7 disrupt these regulatory interactions and result in a neuron-specific increase in ATXN7 expression. Strikingly, in mice this increase is most prominent in the SCA7 disease-relevant tissues, namely the retina and cerebellum. | 25306109 |